加拿大开展治疗性艾滋病毒疫苗试验。

Canadian HIV/AIDS policy & law review Pub Date : 2004-08-01

David Garmaise

{"title":"加拿大开展治疗性艾滋病毒疫苗试验。","authors":"David Garmaise","doi":"","DOIUrl":null,"url":null,"abstract":"The first-ever clinical trial of a therapeutic HIV vaccine in Canada is currently underway. The trial is being run by the Canadian Network for Vaccines and Immunotherapeutics (CANVAC) in cooperation with Aventis Pasteur, of France, and the Immune Response Corporation (IRC), of the United States.","PeriodicalId":83647,"journal":{"name":"Canadian HIV/AIDS policy & law review","volume":"9 2","pages":"44"},"PeriodicalIF":0.0000,"publicationDate":"2004-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Therapeutic HIV vaccine trial launched in Canada.\",\"authors\":\"David Garmaise\",\"doi\":\"\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"The first-ever clinical trial of a therapeutic HIV vaccine in Canada is currently underway. The trial is being run by the Canadian Network for Vaccines and Immunotherapeutics (CANVAC) in cooperation with Aventis Pasteur, of France, and the Immune Response Corporation (IRC), of the United States.\",\"PeriodicalId\":83647,\"journal\":{\"name\":\"Canadian HIV/AIDS policy & law review\",\"volume\":\"9 2\",\"pages\":\"44\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2004-08-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Canadian HIV/AIDS policy & law review\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Canadian HIV/AIDS policy & law review","FirstCategoryId":"1085","ListUrlMain":"","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}

引用次数: 0

摘要

加拿大目前正在进行首个治疗性艾滋病毒疫苗的临床试验。该试验由加拿大疫苗和免疫疗法网络(CANVAC)与法国安万特巴斯德公司和美国免疫反应公司(IRC)合作进行。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

本刊更多论文

Therapeutic HIV vaccine trial launched in Canada.

The first-ever clinical trial of a therapeutic HIV vaccine in Canada is currently underway. The trial is being run by the Canadian Network for Vaccines and Immunotherapeutics (CANVAC) in cooperation with Aventis Pasteur, of France, and the Immune Response Corporation (IRC), of the United States.

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

Canadian HIV/AIDS policy & law review

自引率

0.00%

发文量